These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
451 related items for PubMed ID: 18976288
1. Metronomic therapy with cyclophosphamide and piroxicam effectively delays tumor recurrence in dogs with incompletely resected soft tissue sarcomas. Elmslie RE, Glawe P, Dow SW. J Vet Intern Med; 2008; 22(6):1373-9. PubMed ID: 18976288 [Abstract] [Full Text] [Related]
2. Low-dose cyclophosphamide selectively decreases regulatory T cells and inhibits angiogenesis in dogs with soft tissue sarcoma. Burton JH, Mitchell L, Thamm DH, Dow SW, Biller BJ. J Vet Intern Med; 2011; 25(4):920-6. PubMed ID: 21736624 [Abstract] [Full Text] [Related]
3. Evaluation of toxicities from combined metronomic and maximal-tolerated dose chemotherapy in dogs with osteosarcoma. Bracha S, Walshaw R, Danton T, Holland S, Ruaux C, Obradovich J. J Small Anim Pract; 2014 Jul; 55(7):369-74. PubMed ID: 24803081 [Abstract] [Full Text] [Related]
4. Survival analysis of dogs with advanced primary lung carcinoma treated by metronomic cyclophosphamide, piroxicam and thalidomide. Polton G, Finotello R, Sabattini S, Rossi F, Laganga P, Vasconi ME, Barbanera A, Stiborova K, Rohrer Bley C, Marconato L. Vet Comp Oncol; 2018 Sep; 16(3):399-408. PubMed ID: 29508493 [Abstract] [Full Text] [Related]
5. Soft-tissue sarcomas in dogs: a review. Ehrhart N. J Am Anim Hosp Assoc; 2005 Sep; 41(4):241-6. PubMed ID: 15995161 [Abstract] [Full Text] [Related]
6. Impact of Toceranib/Piroxicam/Cyclophosphamide Maintenance Therapy on Outcome of Dogs with Appendicular Osteosarcoma following Amputation and Carboplatin Chemotherapy: A Multi-Institutional Study. London CA, Gardner HL, Mathie T, Stingle N, Portela R, Pennell ML, Clifford CA, Rosenberg MP, Vail DM, Williams LE, Cronin KL, Wilson-Robles H, Borgatti A, Henry CJ, Bailey DB, Locke J, Northrup NC, Crawford-Jakubiak M, Gill VL, Klein MK, Ruslander DM, Thamm DH, Phillips B, Post G. PLoS One; 2015 Sep; 10(4):e0124889. PubMed ID: 25923466 [Abstract] [Full Text] [Related]
7. Long-term outcomes of dogs undergoing surgical resection of mast cell tumors and soft tissue sarcomas: A prospective 2-year-long study. Milovancev M, Townsend KL, Tuohy JL, Gorman E, Bracha S, Curran KM, Russell DS. Vet Surg; 2020 Jan; 49(1):96-105. PubMed ID: 31044443 [Abstract] [Full Text] [Related]
8. Single high-dose radiation therapy and liquid fiducial markers can be used in dogs with incompletely resected soft tissue sarcomas. Ericksen T, Mauldin N, Dickinson R, Mauldin G. J Am Vet Med Assoc; 2023 Oct 01; 261(10):1-8. PubMed ID: 37437890 [Abstract] [Full Text] [Related]
9. Prognostic factors for surgical treatment of soft-tissue sarcomas in dogs: 75 cases (1986-1996). Kuntz CA, Dernell WS, Powers BE, Devitt C, Straw RC, Withrow SJ. J Am Vet Med Assoc; 1997 Nov 01; 211(9):1147-51. PubMed ID: 9364229 [Abstract] [Full Text] [Related]
10. Evaluation of local toxic effects and outcomes for dogs undergoing marginal tumor excision with intralesional cisplatin-impregnated bead placement for treatment of soft tissue sarcomas: 62 cases (2009-2012). Bergman NS, Urie BK, Pardo AD, Newman RG. J Am Vet Med Assoc; 2016 May 15; 248(10):1148-56. PubMed ID: 27135671 [Abstract] [Full Text] [Related]
11. Evaluation of primary re-excision after recent inadequate resection of soft tissue sarcomas in dogs: 41 cases (1999-2004). Bacon NJ, Dernell WS, Ehrhart N, Powers BE, Withrow SJ. J Am Vet Med Assoc; 2007 Feb 15; 230(4):548-54. PubMed ID: 17302554 [Abstract] [Full Text] [Related]
12. Marginal excision of low-grade spindle cell sarcoma of canine extremities: 35 dogs (1996-2006). Stefanello D, Morello E, Roccabianca P, Iussich S, Nassuato C, Martano M, Squassino C, Avallone G, Romussi S, Buracco P. Vet Surg; 2008 Jul 15; 37(5):461-5. PubMed ID: 18986313 [Abstract] [Full Text] [Related]
13. Radiation treatment for incompletely resected soft-tissue sarcomas in dogs. McKnight JA, Mauldin GN, McEntee MC, Meleo KA, Patnaik AK. J Am Vet Med Assoc; 2000 Jul 15; 217(2):205-10. PubMed ID: 10909459 [Abstract] [Full Text] [Related]
16. Metronomic chemotherapy. Mutsaers AJ. Top Companion Anim Med; 2009 Aug 15; 24(3):137-43. PubMed ID: 19732732 [Abstract] [Full Text] [Related]
17. Tolerability of metronomic administration of lomustine in dogs with cancer. Tripp CD, Fidel J, Anderson CL, Patrick M, Pratt C, Sellon R, Bryan JN. J Vet Intern Med; 2011 Aug 15; 25(2):278-84. PubMed ID: 21314727 [Abstract] [Full Text] [Related]
18. Orthovoltage radiation and weekly low dose of doxorubicin for the treatment of incompletely excised soft-tissue sarcomas in 39 dogs. Simon D, Ruslander DM, Rassnick KM, Wood CA, Frimberger AE, Cotter SM, King NW, Moore AS. Vet Rec; 2007 Mar 10; 160(10):321-6. PubMed ID: 17351172 [Abstract] [Full Text] [Related]
19. Intentional marginal excision of canine limb soft tissue sarcomas followed by radiotherapy. Demetriou JL, Brearley MJ, Constantino-Casas F, Addington C, Dobson J. J Small Anim Pract; 2012 Mar 10; 53(3):174-81. PubMed ID: 22931399 [Abstract] [Full Text] [Related]
20. High dose lansoprazole combined with metronomic chemotherapy: a phase I/II study in companion animals with spontaneously occurring tumors. Spugnini EP, Buglioni S, Carocci F, Francesco M, Vincenzi B, Fanciulli M, Fais S. J Transl Med; 2014 Aug 21; 12():225. PubMed ID: 25143012 [Abstract] [Full Text] [Related] Page: [Next] [New Search]